Status:
UNKNOWN
Metabolomic Study in Huntington's Disease (METABO-HD)
Lead Sponsor:
University Hospital, Angers
Conditions:
Huntington Disease
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
The purpose of this project is to study Huntington's disease by metabolomic approach.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- For all groups:
- age between 20 and 70 years
- signature of the informed consent
- covered by social security
- For presymptomatic group:
- positive genetic test with CAG repeat length ≥ 37 in HTT gene
- Unified Huntington Disease Rating Scale ≤ 5
- For symptomatic group:
- positive genetic test with CAG repeat length ≥ 37 in HTT gene
- The Unified Huntington's Disease Rating Scale motor score ≥ 6
- The Total Functional Capacity score ≥ 11
- Exclusion Criteria for all groups:
- participation in another therapeutic trial (3 months exclusion period)
- pregnancy and breastfeeding
- persons deprived of their liberty by judicial or administrative decision
Exclusion
Key Trial Info
Start Date :
October 9 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2019
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03296176
Start Date
October 9 2017
End Date
September 1 2019
Last Update
November 1 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Angers
Angers, France, 49000